The role of innate and adaptive immune cells in skeletal muscle regeneration
In 2024, the ESC guidelines for elevated blood pressure and hypertension classified GLP-1 RA as therapies that have shown blood pressure-lowering properties but are awaiting further supportive evidence from cardiovascular outcomes trials prior to guideline endorsement and routine use in hypertension [49]
[For example,] a patient whose main issue is inflammation might benefit more from the anti-inflammatory effect of the drug than a patient whose Crohn's disease has led to strictures, [or] a narrowing of the intestine. The Takeaway GLP-1s decrease inflammation throughout the body, and may improve Crohns disease outcomes
Understanding GLP-1 Medications The story of GLP-1 medications began not in weight-loss clinics but in diabetes research
1 in Supplementary Materials
She alleges the GLP-1 receptor agonist drugs caused her to sustain gastroparesis, a serious gastrointestinal condition marked by persistent vomiting, diarrhea, and abdominal pain